Information For Healthcare Professionals

Interim Clinical Considerations for Monkeypox Vaccination

CDC has updated its Interim Clinical Considerations for using the JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak, including an alternative regimen for administering the JYNNEOS vaccine intradermally.

Vaccine Considerations

Caring for Patients

Key Characteristics for Identifying Monkeypox

CDC urges healthcare providers in the U.S. to be alert for patients who have rash illnesses consistent with monkeypox.

Clinical Recognition

What Healthcare Professionals Should Know
Case Definition
Clinical Guidance
NewClinical Considerations for Pain Management
Clinician FAQs

Prevent and Control Monkeypox

Vaccine Information

When properly administered before an exposure, vaccines are effective at protecting people against monkeypox.

Vaccines

Infection Control
Specimen Collection

Other Resources

What Clinicians Need to Know about Monkeypox (June 2022) [2.8 MB, 59 pages]
Reducing Stigma in Monkeypox Communication and Community Engagement

Page last reviewed: September 15, 2022

Content source: Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP)